Stock listing
Qyuns Therapeutics Co., Ltd. Class H
Selected listing: 2509 · HKEX · HKD · HK
Qyuns Therapeutics Co., Ltd. Class H (HKEX:2509), Health Technology. Latest release Oct 2, 2026: VOLUNTARY ANNOUNCEMENT PHASE III CLINICAL STUDY RESULTS…
- Ticker
- HKEX:2509
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- HKEX
- Currency
- HKD
About Qyuns Therapeutics Co., Ltd. Class H
Qyuns Therapeutics Co., Ltd. Class H is a publicly traded company on the Hong Kong Stock Exchange under the ticker 2509. Qyuns focuses on developing innovative therapeutic solutions in the healthcare sector.
Latest news from Qyuns Therapeutics Co., Ltd. Class H
VOLUNTARY ANNOUNCEMENT PHASE III CLINICAL STUDY RESULTS OF OTURKIBART (QX005N) FOR TREATMENT OF PRURIGO NODULARIS PRESENTED AS A LATE-BREAKING ORAL PRESENTATION AT EADV 2026
October 1, 2026
A Decade of Persistent Steps, Aspiring for a Thousand Miles: Qyuns' Grand 10th Anniversary Celebration Held Successfully
June 16, 2025
Research Qyuns Therapeutics Co., Ltd. Class H
Qyuns Therapeutics Co., Ltd. Class H company profile
View the public company page for Qyuns Therapeutics Co., Ltd. Class H on 6ix.
Qyuns Therapeutics Co., Ltd. Class H news
Read company news and market updates connected to Qyuns Therapeutics Co., Ltd. Class H.
Qyuns Therapeutics Co., Ltd. Class H investor events
Find investor webinars, events, and replay context for Qyuns Therapeutics Co., Ltd. Class H.